{"slideshow_credits": null, "snippet": "In its offer to buy Hospira, Pfizer is paying richly for what it believes will be a lucrative source of future revenue, drugs known as biosimilars.", "abstract": "In its offer to buy Hospira, Pfizer is paying richly for what it believes will be a lucrative source of future revenue, drugs known as biosimilars.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}, {"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 2, "organization": ""}], "original": "By DAVID GELLES and KATIE THOMAS"}, "web_url": "http://dealbook.nytimes.com/2015/02/05/pfizer-to-buy-hospira-a-drug-maker-for-15-2-billion-in-cash/", "lead_paragraph": null, "headline": {"main": "Pfizer Bets $15 Billion on New Class of Generic Drugs", "print_headline": "Pfizer Bets $15 Billion on New Sort of Generics", "kicker": "DealBook"}, "_id": "54d3618c38f0d81f788a23f8", "word_count": "1218", "multimedia": [{"height": 126, "url": "images/2015/02/06/business/06DRUG/06DRUG-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/02/06/business/06DRUG/06DRUG-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 415, "url": "images/2015/02/06/business/06DRUG/06DRUG-articleLarge.jpg", "legacy": {"xlarge": "images/2015/02/06/business/06DRUG/06DRUG-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "415"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/02/06/business/06DRUG/06DRUG-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/02/06/business/06DRUG/06DRUG-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-02-05T07:24:35Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Hospira Inc", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Pfizer Inc", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}